Kentucky Retirement Systems’s Royalty Pharma RPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.52M Buy
26,046
+1,777
+7% +$105K 0.04% 362
2026
Q2
$1.36M Buy
+24,269
New +$1.26M 0.03% 377
2026
Q1
– Sell
-23,804
Closed -$920K – 649
2025
Q4
$920K Hold
23,804
– – 0.02% 453
2025
Q3
$840K Sell
23,804
-896
-4% -$32.4K 0.02% 465
2025
Q2
$890K Sell
24,700
-1,618
-6% -$53.6K 0.03% 449
2025
Q1
$819K Buy
+26,318
New +$834K 0.03% 465

Other funds holding RPRX

Kentucky Retirement Systems's RPRX Position: Q3 2026 in Review

Kentucky Retirement Systems increased its Royalty Pharma (RPRX) stake by 7.3% in Q3 2026, buying an estimated $105K and bringing the position to 26,046 shares worth $1.52M. The position accounts for 0.04% of the portfolio, ranked #362.

Kentucky Retirement Systems first reported a position in RPRX in Q1 2025 and has held it in 6 quarters since. 707 funds tracked by Wall St. Rank hold RPRX as of Q3 2026.

  • Kentucky Retirement Systems held 26,046 shares of Royalty Pharma worth $1.52M as of Q3 2026.
  • Kentucky Retirement Systems bought 1,777 Royalty Pharma shares in Q3 2026, an estimated $105K.
  • Royalty Pharma made up 0.04% of Kentucky Retirement Systems's portfolio in Q3 2026, its #362 holding.
  • Kentucky Retirement Systems first reported a position in Royalty Pharma in Q1 2025 and has held it in 6 quarters since.
  • 707 funds tracked by Wall St. Rank held Royalty Pharma as of Q3 2026.

Based on Kentucky Retirement Systems's 13F filing for Q3 2026, filed 17 Nov 2026.